Abstract
In this work, we present our strategy for developing domain-specific large language models which cover the vocabulary of the target domain and train on reliable sources of clinical information. Prostate cancer was chosen as a use-case for this study. We collected more than 1.8 million clinical notes and radiology and pathology reports for 15341 patients treated for prostate cancer in Mayo Clinic across three sites and outpatient clinics. In addition to domain-specific training data, we built domain-specific tokenizers and devised knowledge-guided training strategies for LLM development. During the self-supervised training, LLM was forced to predict domain-specific information by marking clinical terms using UMLS parser. We evaluated the model for downstream tasks of clinical information prediction and question answering using quantitative and user evaluation study to measure the accuracy, reliability and information completeness. We compared the domain-specific model against similarly sized general purpose model GPT-2 and a three-times larger domain specialized model. i.e., BioGPT. Our model outperformed GPT-2 on both tasks by a wide margin. Our model was also able to outperform BioGPT on clinical information prediction tasks and showed some advantages over BioGPT in question-answering tasks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Internal Review Board (IRB) of Mayo Clinic gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
